AU8016894A - Betaglycan polypeptides having tgf-beta binding activity - Google Patents
Betaglycan polypeptides having tgf-beta binding activityInfo
- Publication number
- AU8016894A AU8016894A AU80168/94A AU8016894A AU8016894A AU 8016894 A AU8016894 A AU 8016894A AU 80168/94 A AU80168/94 A AU 80168/94A AU 8016894 A AU8016894 A AU 8016894A AU 8016894 A AU8016894 A AU 8016894A
- Authority
- AU
- Australia
- Prior art keywords
- tgf
- binding activity
- beta binding
- betaglycan polypeptides
- betaglycan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102100033663 Transforming growth factor beta receptor type 3 Human genes 0.000 title 1
- 108010079292 betaglycan Proteins 0.000 title 1
- 230000027455 binding Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13836893A | 1993-10-15 | 1993-10-15 | |
| US138368 | 1993-10-15 | ||
| PCT/US1994/011648 WO1995010610A1 (en) | 1993-10-15 | 1994-10-14 | BETAGLYCAN POLYPEPTIDES HAVING TGF-β BINDING ACTIVITY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU8016894A true AU8016894A (en) | 1995-05-04 |
Family
ID=22481710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU80168/94A Abandoned AU8016894A (en) | 1993-10-15 | 1994-10-14 | Betaglycan polypeptides having tgf-beta binding activity |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU8016894A (en) |
| WO (1) | WO1995010610A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69332026T2 (en) * | 1992-10-29 | 2002-10-31 | Celtrix Pharmaceuticals, Inc. | TYPE II TGF-BETA BINDING RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT |
| GB2304045A (en) * | 1995-08-04 | 1997-03-12 | Univ Manchester | Betaglycan compositions for promoting the healing of wounds and fibrotic diseases |
| AU777166B2 (en) * | 1999-12-15 | 2004-10-07 | Research Development Foundation | Betaglycan as an inhibin receptor and uses thereof |
| US20070184052A1 (en) * | 2003-05-09 | 2007-08-09 | Lin Herbert Y | Soluble tgf-b type III receptor fusion proteins |
| MXPA03004172A (en) * | 2003-05-13 | 2004-11-18 | Univ Mexico Nacional Autonoma | Treatment kit which assists with antibiotic therapy for intracellular infectious diseases. |
| WO2005097832A2 (en) | 2004-03-31 | 2005-10-20 | Genentech, Inc. | Humanized anti-tgf-beta antibodies |
| GB0426960D0 (en) | 2004-12-08 | 2005-01-12 | Ares Trading Sa | TGR-3 like protein receptor |
| JP5602365B2 (en) | 2005-10-25 | 2014-10-08 | ザ・ジョンズ・ホプキンス・ユニバーシティ | Methods and compositions for treating Marfan syndrome and related diseases. |
| EP1998810A4 (en) | 2006-03-13 | 2009-09-02 | Univ Johns Hopkins | INCREASE IN ENDOTHELIAL THROMBORISISTANCE |
| HUE035575T2 (en) | 2006-10-03 | 2018-05-28 | Genzyme Corp | Use of TGF beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia |
| EP2660314A4 (en) | 2010-12-27 | 2014-09-03 | Lsip Llc | iPS CELLS AND METHOD FOR GENERATING SAME |
| EP2737083A1 (en) | 2011-07-27 | 2014-06-04 | INSERM (Institut National de la Santé et de la Recherche Scientifique) | Methods for diagnosing and treating myhre syndrome |
| BR112014009789A2 (en) | 2011-10-26 | 2017-04-25 | Seattle Children's Res Inst | cysteamine in the treatment of fibrotic disease |
| EP3553169B1 (en) | 2011-12-28 | 2021-11-03 | Kyoto Prefectural Public University Corporation | Normalization of culture of corneal endothelial cells |
| MX383328B (en) | 2013-10-31 | 2025-03-13 | Kyoto Prefectural Public Univ Corp | THERAPEUTIC DRUG FOR DISEASES RELATED TO CELL DEATH OF THE ENDOPLASMIC RETICULUM IN THE CORNEAL ENDOTHELIUM. |
| US10882903B2 (en) | 2015-05-18 | 2021-01-05 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and compositions for treating an alphavirus infection |
| WO2020201362A2 (en) | 2019-04-02 | 2020-10-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of predicting and preventing cancer in patients having premalignant lesions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993010215A1 (en) * | 1991-11-15 | 1993-05-27 | Memorial Sloan-Kettering Cancer Center | Purified proteoglycan betaglycan, compositions, and methods |
-
1994
- 1994-10-14 AU AU80168/94A patent/AU8016894A/en not_active Abandoned
- 1994-10-14 WO PCT/US1994/011648 patent/WO1995010610A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995010610A1 (en) | 1995-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1321895A (en) | Binding assay | |
| AU2662795A (en) | Cdk4 binding proteins | |
| AU4370596A (en) | Novel hedgehog-derived polypeptides | |
| AU7978694A (en) | Catalytic dna | |
| AU5283793A (en) | Recombinant specific binding protein | |
| AU2919197A (en) | Flat antenna | |
| ZA947122B (en) | Drug binding protein. | |
| AU5926194A (en) | Catalyst composition | |
| AU2527497A (en) | Puzzle book | |
| AU3216797A (en) | Novel heparin binding peptides | |
| AU8016894A (en) | Betaglycan polypeptides having tgf-beta binding activity | |
| AU1372795A (en) | Catalyst composition | |
| AU6472994A (en) | Card | |
| AU671148C (en) | Binding element | |
| AU6939594A (en) | Stapler | |
| GB9326451D0 (en) | Binding assay | |
| AU4312697A (en) | Catalysts | |
| AU5384596A (en) | Binding assembly | |
| AU1475597A (en) | Rapid-freezing container | |
| AU3640397A (en) | Ob protein binding protein | |
| AU1235597A (en) | Fibrinogen binding peptides | |
| AU8139594A (en) | Microtome | |
| AU4586497A (en) | Calcium-integrin binding protein | |
| AU2379397A (en) | Container | |
| AU2435295A (en) | Binding assembly |